Mediget Teshome named chief of breast surgery at UCLA Health

Exercise during chemotherapy for breast cancer improves quality of life, Sylvester-led study finds

For many women with breast cancer, the treatment that saves their lives also brings fatigue that clings like a heavy coat, loss of muscle mass that turns everyday tasks into obstacles and emotional strain that lingers long after each infusion ends. It’s a season defined not just by survival, but by how well patients are able to live through it.

February 27, 2026

Vol.52 No.08

In Brief

Indiana University receives $5M grant to expand breast cancer diagnosis, care in Kenya

The Indiana University Melvin and Bren Simon Comprehensive Cancer Center has been awarded a $5 million grant from the Pfizer Foundation to expand access to timely breast cancer diagnosis, treatment, and care in Kenya.

February 20, 2026

Vol.52 No.07

Clinical Roundup

Exposure to pathogenic bacteria significantly increased SMOX activity, leading growth and metastasis of breast cancer, JHU-led study finds

Researchers at the Johns Hopkins Kimmel Cancer Center have discovered how certain pathogenic bacteria in gut and breast tissue can promote breast cancer development and progression by hijacking a key metabolic enzyme known as spermine oxidase.

February 20, 2026

Vol.52 No.07

Clinical Roundup

Advanced PET/CT imaging can improve long-term outcomes in recurrent prostate cancer, UCLA-led study finds

A five-year retrospective study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that prostate-specific membrane antigen PET/CT scans can help doctors target treatment more precisely for men whose prostate cancer returns after surgery, improving long-term outcomes and potentially reducing unnecessary side effects.

February 13, 2026

Vol.52 No.06

Clinical Roundup

Rural cancer patients do just as well as urban patients when having surgery close to home, study finds

Adults living in rural communities often travel long distances when seeking treatment for cancer, but distant travel may not always be necessary to receive high-quality surgical care.

February 13, 2026

Vol.52 No.06

Clinical Roundup

NCCN updates guidelines recognizing MammaPrint to guide personalized anthracycline use in HR+/HER2- early‑stage breast cancer

The NCCN added MammaPrint + BluePrint to the Clinical Practice Guidelines in Oncology for the identification of a subset of hormone receptor positive, HER2-negative early-stage breast cancer patients most likely to benefit from anthracycline-based chemotherapy.

February 06, 2026

Vol.52 No.05

Mediget Teshome named chief of breast surgery at UCLA Health

YOU MAY BE INTERESTED IN

Exercise during chemotherapy for breast cancer improves quality of life, Sylvester-led study finds

Indiana University receives $5M grant to expand breast cancer diagnosis, care in Kenya

Exposure to pathogenic bacteria significantly increased SMOX activity, leading growth and metastasis of breast cancer, JHU-led study finds

Advanced PET/CT imaging can improve long-term outcomes in recurrent prostate cancer, UCLA-led study finds

Rural cancer patients do just as well as urban patients when having surgery close to home, study finds

NCCN updates guidelines recognizing MammaPrint to guide personalized anthracycline use in HR+/HER2- early‑stage breast cancer

Renew today!

Subscriber content

Never miss an issue!

Login